发明名称 Interlaced method for treating cancer or a precancerous condition
摘要 The present invention provides a method for treating a disease or condition in a mammal which comprises the steps of; administering a therapeutically effective amount of a T type calcium channel inhibitor to effectively slow or stop progression of eukaryotic cells through the S, G and M phases of the cell cycle to increase the proportion of the eukaryotic cells in the G phase, stopping administration of the T type calcium channel inhibitor for a period of time, and administering a dosage selected from the group consisting of a dosage of at least one chemotherapeutic agent, a dosage of radiation, and combinations thereof, to kill the proportion of eukaryotic cells progressing past the G phase of the cell cycle after the stopping of the administration of the T type calcium channel inhibitor.
申请公布号 AU2010256442(A1) 申请公布日期 2012.01.19
申请号 AU20100256442 申请日期 2010.06.04
申请人 TAU THERAPEUTICS LLC 发明人 KROUSE, ANDREW J.;GRAY, LLOYD S.;MACDONALD, TIMOTHY;LINDEN, JOEL
分类号 A61K31/70;A61K38/16;A61K48/00;A61P35/00 主分类号 A61K31/70
代理机构 代理人
主权项
地址